基于慕太师中空多功能枕改善睡眠障碍的初步探讨
2018-10-21刘西芳刘颍利郑思思邬光福汪卫东
刘西芳 刘颍利 郑思思 邬光福 汪卫东

摘要 目的:初步探讨慕太师中空多功能枕改善睡眠障碍的临床疗效。方法:选取2018年5月至2018年7月于我院就诊的睡眠障碍患者30人被试,使用慕太师中空多功能枕30天并且前后测量匹兹堡睡眠质量指数量表(PSQI)和症状自评量表(SCL-90)。结果:PSQI分数差异有统计学意义( P <0.001),且PSQI分数呈降低趋势。SCL-90整体情况分数差异均有统计学意义( P <0.05),且阳性症状分数减少,阴性症状分数增加。SCL-90细分情况显示,除人际敏感、恐怖、精神病性、敌对、强迫等项目外,其余项目差异均有统计学意义( P <0.05)。结论:慕太师中空多功能枕可以改善睡眠障碍并减少不良情绪体验。
关键词 睡眠枕头;睡眠障碍;SCL-90
中图分类号:R338.63 文献标识码:A doi: 10.3969/j.issn.2095-7130.2018.10.001
Preliminary Discussion on Improving Sleep Disorders Based on Mutaishi Pillow
Liu Xifang,Liu Yingli,Zheng Sisi,Wu Guangfu,Wang Weidong
(Department of Sleep Medicine,Guang′anmen Hospital,China Academy of Chinese Medical Sciences,Beijing,100053)
Abstract Objective: To initially explore the improvement of sleep disorders by Mutaishi pillow. Methods: Thirty patients with sleep disorders admitted to our hospital from May 2018 to July 2018 were enrolled.The PSQI and SCL-90 were measured before and after using pillow 30 days. Results: PSQI scores were statistically significant ( P <0.001) and PSQI scores showed a decreasing trend.The SCL-90 overall condition scores were statistically significant ( P <0.05),and the positive symptom scores decreased,and the negative symptom scores increased.The SCL-90 subdivision showed that except for interpersonal sensitivity,terror,psychosis,hostility,and coercion,the other items were statistically significant ( P <0.05). Conclusion: Mutaishi hollow multifunctional pillow improved sleep disorders and reduced adverse emotional experience.
Key Words Sleep pillow; Sleep disorder;SCL-90
睡眠作為生命所必需的过程,是机体复原和整合的重要环节。最新调查结果显示,中国成年人失眠发生率高达38.2%,超过3亿人口有睡眠障碍,这已经成为威胁人们健康的巨大隐患。目前,在医院临床中治疗睡眠障碍的方法是以药物为主。但是,长期服用安眠药会产生一定的不良反应,而且治疗效果参差不齐。因此,研发更加便捷、安全的改善睡眠障碍的产品已经势在必行。本文基于慕太师中空多功能枕改善睡眠障碍的疗效进行初步探讨,以便于为睡眠障碍的治疗提供新思路。
1 资料与方法
1.1 一般资料 选取2018年5月至2018年7月于我院就诊的睡眠障碍30例被试者,试验中途脱落1例,实收被试者29例,男13例,女16例,平均年龄(45.70±3.278)岁,按性别进行分组,各因子差异无统计学意义,具有可比性。
1.2 纳入标准 1)年龄在18~80岁之间的睡眠障碍患者、男女不限;2)受试者签署知情同意书。
1.3 排除标准 1)采用影响本试验观察的药物治疗或非药物治疗方法的受试者;2)妊娠或者哺乳期的受试者;3)严重心、肝、肺、肾等器质性疾病者:4)精神疾病或者不具备自主能力的受试者;5)近3个月内参加过其他临床试验的受试者。……
